Custodiol® HTK
Organ Preservation for Transplantation
ApprovedActive
Key Facts
Indication
Organ Preservation for Transplantation
Phase
Approved
Status
Active
Company
About Essential Pharmaceuticals
Essential Pharmaceuticals is a commercial-stage biopharmaceutical company specializing in the transplant medicine market with its cornerstone product, Custodiol® HTK. Acquired by Accord Healthcare in 2017, the company leverages a focused sales and marketing team to serve a well-defined niche. Its business is centered on a single, established product, positioning it as a specialized player in the cardiovascular and organ preservation space, with a historical focus that also includes metabolic and rare diseases.
View full company profileTherapeutic Areas
Other Organ Preservation for Transplantation Drugs
| Drug | Company | Phase |
|---|---|---|
| Reversible Cryopreservation System for Donor Organs | Until Labs | Pre-clinical |